Literature DB >> 18436070

Malpractice in dermatopathology: principles, risk mitigation, and opportunities for improved care for the histologic diagnosis of melanoma and pigmented lesions.

Whitney A High1.   

Abstract

Melanoma represents a substantial source of risk within dermatology and dermatopathology. This article seeks to provide general pathologists, dermatologists and dermatopathologists with an overview of the basics principles of medical malpractice litigation, a review of the essentials of reporting and the importance of expert consultation for melanoma and pigmented lesions, and suggestions to improve quality care and reduce medicolegal risk associated with melanoma and pigmented lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18436070     DOI: 10.1016/j.cll.2007.12.006

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  3 in total

Review 1.  Survival is not the only valuable end point in melanoma screening.

Authors:  Clara Curiel-Lewandrowski; Caroline C Kim; Susan M Swetter; Suephy C Chen; Allan C Halpern; John M Kirkwood; Sancy A Leachman; Ashfaq A Marghoob; Michael E Ming; James M Grichnik
Journal:  J Invest Dermatol       Date:  2012-02-16       Impact factor: 8.551

2.  Characteristics of State and Federal Malpractice Litigation of Medical Liability Claims for Keratinocyte Carcinoma, 1968 to 2018.

Authors:  Raghav Tripathi; Harib H Ezaldein; Krithika Rajkumar; Jeremy S Bordeaux; Jeffrey F Scott
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

3.  How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions.

Authors:  Patricia A Carney; Paul D Frederick; Lisa M Reisch; Stevan Knezevich; Michael W Piepkorn; Raymond L Barnhill; David E Elder; Berta M Geller; Linda Titus; Martin A Weinstock; Heidi D Nelson; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2015-11-11       Impact factor: 11.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.